Navigation Links
BioDelivery Sciences Provides Business Update and Summary of Third Quarter Results of Operations
Date:11/8/2012

ersify its existing portfolio. 

About BioDelivery Sciences International

BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics.  BDSI is focusing on developing products to meet unmet patient needs in the areas of pain management and addiction.  BDSI's pain franchise currently consists of two products utilizing the patented BEMA technology.  ONSOLIS (fentanyl buccal soluble film) is approved in the U.S., Canada, and the E.U. (where it is marketed as BREAKYL), for the management of breakthrough pain in opioid tolerant, adult patients with cancer.  The commercial rights are licensed to Meda for all territories worldwide except for Taiwan (licensed to TTY Biopharm) and South Korea (licensed to Kunwha Pharmaceutical Co.).  BDSI's second pain product, BEMA Buprenorphine, is being developed for the treatment of moderate to severe chronic pain and is in development in a high dose formulation with naloxone for the treatment of opioid dependence.  BEMA Buprenorphine for chronic pain is licensed on a worldwide basis to Endo Health Solutions.  BDSI's headquarters is located in Raleigh, North Carolina.  For more information, visit www.bdsi.com.

BDSI® and BEMA® are registered trademarks of BioDelivery Sciences International, Inc.  ONSOLIS® is a registered trademark of Meda Pharmaceuticals, Inc.  BREAKYL™ is registered trademark of Meda Pharma GmbH & Co. KG.

Cautionary Note on Forward-Looking Statements

This press release and any statements of representatives and
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
2. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
3. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
4. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
5. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
6. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
7. Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference
8. Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics
9. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
10. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
11. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... BOSTON , December 15, 2014 /PRNewswire/ ... drug discovery and development company, is pleased to announce ... the United States relating to its GPCR-focused ... the US significantly strengthens the global patent estate covering ... The suite of patents recently granted by ...
(Date:12/13/2014)...  Radiologists can transmit their reports, which can ... physicians, electronic health records (EHR) systems securely, efficiently, ... That was the message behind a ... the recent Radiology Society of North America Meeting ... in this manner also helps referring physicians satisfy ...
(Date:12/13/2014)... , Dec. 12, 2014  Novo Nordisk, a world ... today announced a multi-year extension of their partnership, that will ... 83 Novo Nordisk Chip Ganassi Racing entry, driven by ... Kimball, 29, from Camarillo, California , ... the history of INDYCAR to win a race at the ...
Breaking Medicine Technology:Heptares Extends Global Patent Protection for GPCR-Focused Drug Discovery Platform With Grant of Core Patents in the United States 2Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 2Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 2Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 3Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 4Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 5Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 6Novo Nordisk and Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement for Verizon IndyCar Series 7
... 31, 2011 Thoratec Corporation (Nasdaq: THOR ), ... save, support and restore failing hearts, announced today that it ... the outstanding Senior Subordinated Convertible Notes due 2034 (CUSIP No. ... 30, 2011 there were 243,382 notes outstanding, which can be ...
... 31, 2011 Conatus Pharmaceuticals Inc. announced today ... CTS-1027 in combination with Peginterferon Alpha-2a (Pegasys®) and ... virus (HCV) null-responder patient population.  Null-responder patients are ... are clinically defined as those patients failing to ...
Cached Medicine Technology:Thoratec Corporation Announces Redemption of Senior Subordinated Convertible Notes Due 2034 2Thoratec Corporation Announces Redemption of Senior Subordinated Convertible Notes Due 2034 3Conatus Pharmaceuticals Presents Results From a Phase 2 Clinical Trial of CTS-1027 in HCV Genotype 1 Null-Responders 2
(Date:12/15/2014)... OutMarket , a provider of marketing automation ... Sheets ,” a guide that exposes the insider secrets ... top ten social media networks. , Social media ... and customer service. It can also increase new leads ... new networks and weather constantly changing algorithms, they need ...
(Date:12/15/2014)... Steven Reinberg HealthDay Reporter ... large, new study should reassure the millions of American women ... for breast cancer. "There is no association between migraine ... associate professor of medicine at Harvard Medical School. "There is ... and there is no protective effect either." About 18 ...
(Date:12/15/2014)... The increase in prevalence of disabling hearing loss in the ... contributing to the growth in the global audiological market. Devices ... loss and balance disorders are known as audiological devices. An ... amplifier. The global market is expected to grow at a ... 2014 to 2019. Some of the factors which are driving ...
(Date:12/15/2014)... Emergo Group, Inc., a medical device ... North and South America, Europe, the Middle East, Asia ... for its 2015 Medical Device Industry Survey. Each year, ... business and market trends as well as regulatory and ... areas including:, , Overall prospects for ...
(Date:12/15/2014)... CA (PRWEB) December 15, 2014 At ... the organizations AutismOne and Focus Autism ... enlighten attendees with research on the effects of toxins ... testing and intervention information. , Luminaries such as ... researchers from abroad with esteemed, credentialed colleagues of the ...
Breaking Medicine News(10 mins):Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH) today announced ... Board and a member of the Board of Directors ... the Company. John L.,McGoldrick, a current Board member, will ... Chairman, President and Chief Executive Officer,of the Company from ...
... Gen-Probe Incorporated,(Nasdaq: GPRO ) announced today that ... in London on Thursday, December 6, 2007 at,approximately 10:45 ... is scheduled to be webcast live and may be ... Gen-Probe,s website at, http://www.gen-probe.com . The webcast will be ...
... J. Robert Scott, a leading,retainer-based executive search ... in,professional services; and the internationally recognized law ... Harvard Business School,have released data for their ... available at http://www.compstudy.com . This study ...
... Covance Sells Centralized ECG Business; Enters Exclusive Ten Year ... Marketing Agreement with eRT ... today that it has agreed to sell its centralized ECG,business to ... its clients cardiac safety services through eRT,s robust,centralized ECG platform. The ...
... N-Myc gene lives a double life, triggering cancer when ... suicide in the absence,of IL-3, MEMPHIS, Tenn., Nov. ... in certain white blood cells when it is overexpressed,helping ... while,triggering apoptosis, or cell suicide, under other conditions, according ...
... U.S. Career Institute, a,nationally accredited distance learning school, ... Assistant career training course.,The Medical Assistant course is their ... "The Medical Assistant course is a big step for ... school," said Ann Rohr,president of U.S. Career Institute. "Our ...
Cached Medicine News:Health News:Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman 2Health News:Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman 3Health News:Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program 2Health News:2007 Life Sciences Compensation Findings Disclosed www.compstudy.com 2Health News:2007 Life Sciences Compensation Findings Disclosed www.compstudy.com 3Health News:2007 Life Sciences Compensation Findings Disclosed www.compstudy.com 4Health News:Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRT's Centralized Cardiac Safety Services 2Health News:Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRT's Centralized Cardiac Safety Services 3Health News:St. Jude Researchers Identify Key Genetic Trigger of Acute Myeloid Leukemia 2Health News:U.S. Career Institute Launches 1st Ever DETC Accredited Medical Assistant Course 2
... Packed conveniently in plastic-wrapped racks of 96 ... useno need to autoclave. Sterilized Diamond Tips ... sterilization and are delivered with a certificate ... Sterilized Diamond Tips are certified free of ...
... Finntips have been designed to optimize the ... of our tip products is widely recognized ... range has been extended over the years ... standard and special tips including filter tips, ...
This large orifice 1000 ul tips is the large volume alternative to MBP's 200G tip. Pipet fragile cells, viscous samples and genomic DNA with ease....
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
Medicine Products: